Total cases (%) 111,495 | PTA (n = 41,987, 37.6%) | Bypass (n = 12,334, 11.1%) | Amputation (n = 57,174, 51.3%) | p-value (χ2test) | Crude OR (95% CI) | ||||
---|---|---|---|---|---|---|---|---|---|
No. | (%) | No. | (%) | No. | (%) | ||||
Gender | |||||||||
Male | 60,187 (59.5%) | 25,372 | 60.4 | 7,772 | 63.0 | 33,366 | 58.4 | <0.001 | |
Female | 40,936 (40.5%) | 16,615 | 39.6 | 4,562 | 37.0 | 23,808 | 41.6 a | 1.12 a (1.09-1.14) | |
Age Stratum | |||||||||
30–49.9 y/o | 7,063 (7.0%) | 2,594 | 6.2 | 748 | 6.1 | 4,182 | 7.3 a | <0.001 | 1.30 a (1. 24–1.37) |
50–64.9 y/o | 26,138 (25.8%) | 10,405 | 24.8 | 2,704 | 21.9 | 15,317 | 26.8 a | 1. 22 a (1.18-1.25) | |
65–74.9 y/o | 31,070 (30.7%) | 12,820 | 30.5 | 4,107 | 33.3 b | 17,537 | 30.7 | 1.03 b (0.98-1.08) | |
> = 75y/o | 36,866 (36.5%) | 16,169 | 38.5 | 4,775 | 38.7 | 20,138 | 35.2 | ||
Diabetes | |||||||||
Yes | 69,026 (68.2%) | 20,282 | 48.3 | 6,978 | 56.6 | 48,318 | 84.5 a | <0.001 | 6.12 a (5.95-6.31) |
Hypertension | |||||||||
Yes | 45,961 (45.4%) | 25,844 | 61.5 c | 5,918 | 48.0 | 18,635 | 32.6 | <0.001 | 3.11 c (3.03-3.19) |
ESRD | |||||||||
Yes | 11,318 (11.2%) | 4,094 | 9.7 | 1,741 | 14.1 b | 6,313 | 11.0 | <0.001 | 1.36 b (1.29-1.44) |
CAD | |||||||||
Yes | 16,072 (15.9%) | 10,727 | 25.5 c | 2,254 | 18.3 | 4,635 | 8.1 | <0.001 | 3.45 c (3.33-3.58) |
Dyslipidemia | |||||||||
Yes | 4,803 (4.7%) | 3,960 | 9.4 c | 438 | 3.6 | 690 | 1.2 | <0.001 | 7.20 c (6.68-7.77) |
Group identified | |||||||||
Normal | 72,520 (71.7%) | 27,500 | 65.5 | 9,530 | 77.3 | 43,391 | 75.9 | <0.001 | |
Low-income | 2,704 (2.7%) | 875 | 2.1 | 249 | 2.0 | 1,831 | 3.2 a | 1.41 a (1.30-1.53) | |
CIR | 25,913 (25.6%) | 13,620 | 32.4 c | 2,557 | 20.7 | 11,957 | 20.9 | 1.81 c (1.76-1.87) |